Danske Bank A S Invests $276.54 Million in Merck KGaA $MKGAF

Danske Bank A S acquired a new stake in shares of Merck KGaA (OTCMKTS:MKGAF) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,152,022 shares of the company’s stock, valued at approximately $276,535,000. Merck KGaA makes up 0.5% of Danske Bank A S’s investment portfolio, making the stock its 29th largest position. Danske Bank A S owned approximately 1.67% of Merck KGaA at the end of the most recent reporting period.

Separately, Diversify Advisory Services LLC acquired a new position in Merck KGaA in the 2nd quarter worth about $3,810,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Stock Performance

OTCMKTS MKGAF opened at $160.21 on Wednesday. The stock has a fifty day simple moving average of $162.32 and a 200 day simple moving average of $148.21. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a market capitalization of $20.71 billion, a price-to-earnings ratio of 24.46 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.